Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Frates James M sold 40,000 Amylyx Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 9 to Nov 10, 2026 · Filed Nov 12, 2026
From Nov 9 to Nov 10, 2026, Frates James M (Chief Financial Officer) sold 40,000 Amylyx Pharmaceuticals, Inc. shares at an average US$30.19 for US$1.21M under a trading plan, leaving 233,625 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 40,000 shares
- Price
- US$30.19 average (US$29.39 to US$30.97)
- Value
- US$1.21M
- Holding after
- 233,625 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Common Stock | Option exercise | 20,000 | US$6.88 | 253,625 | Direct |
| Nov 9, 2026 | Common Stock | Sale | 7,700 | US$29.39 | 245,925 | Direct |
| Nov 9, 2026 | Common Stock | Sale | 12,300 | US$30.11 | 233,625 | Direct |
| Nov 10, 2026 | Common Stock | Option exercise | 20,000 | US$6.88 | 253,625 | Direct |
| Nov 10, 2026 | Common Stock | Sale | 12,800 | US$30.32 | 240,825 | Direct |
| Nov 10, 2026 | Common Stock | Sale | 7,200 | US$30.97 | 233,625 | Direct |
Source
Download original · View original at SEC
Related
- Amylyx Pharmaceuticals, Inc.
- Frates James M
- Amylyx Pharmaceuticals, Inc. shareholders
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Frates James M · Aug 20, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 16, 2026
- Schedule 13G/A · Commodore Capital LP · Nov 16, 2026
- Form 4 · Klee Justin B. · Nov 12, 2026
- Form 4 · Cohen Joshua B · Nov 12, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026